Arkolith/Insider Trading/TYRA/Form 4

Harris Todd

President and CEO, DirectorTyra Biosciences, Inc. (TYRA) · full profile →Form 4 · filed Oct 22, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.7M
Net Open-Market Flow
-$1.7M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 21, 2024Sell(S)13K$28.16$371K1.4M
Oct 21, 2024Sell(S)6K$27.32$161K1.4M
Oct 18, 2024Sell(S)44K$27.01$1.2M1.4M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-24-116345) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML